Process / pipelinehealthcare financial planning

Budget Impact Analysis (BIA)

Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a budgetary question: 'If we adopt this new drug/device, how much will it cost our health system next year?' Widely used by hospital procurement committees, insurance formularies, and government health budgets to assess financial feasibility and reimbursement decision.

Apply with EconMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5-14. DOI: 10.1016/j.jval.2013.08.2291
  2. Klok, R. M., Brouwers, J. R., Postma, M. J., et al. (2005). Budget-impact analysis: a systematic literature review of implementation studies. The Annals of Pharmacotherapy, 39(3), 518-526. DOI: 10.1345/aph.1E337
  3. Canadian Agency for Drugs and Technologies in Health (CADTH). (2017). Guidelines for the Economic Evaluation of Health Technologies: Canada (4th ed.). Ottawa: CADTH. link

Related methods

Referenced by

ScholarGateBudget Impact Analysis (Budget Impact Analysis (BIA)). Retrieved 2026-06-04 from https://scholargate.app/en/health-economics/budget-impact-analysis